---
title: "Lenvatinib - Thyroid Cancer, Papillary - 2"
sidebar: mydoc_sidebar
permalink: db09078-mesh-d000077273-2.html
toc: false 
---


Path ID: `DB09078_MESH_D000077273_2`
{% include image.html url="images/db09078-mesh-d000077273-2.png" file="db09078-mesh-d000077273-2.png" alt="db09078-mesh-d000077273-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C531958">MESH:C531958 </a> | lenvatinib | Drug |
| <a href="https://identifiers.org/InterPro:IPR016248">InterPro:IPR016248 </a> | Fibroblast growth factor receptor family | GeneFamily |
| <a href="https://identifiers.org/GO:0008283">GO:0008283 </a> | cell population proliferation | BiologicalProcess |
| <a href="https://identifiers.org/CL:0001064">CL:0001064 </a> | malignant cell | Cell |
| <a href="https://identifiers.org/MESH:D000077273">MESH:D000077273 </a> | Thyroid Cancer, Papillary | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lenvatinib | DECREASES ACTIVITY OF | Fibroblast Growth Factor Receptor Family |
| Fibroblast Growth Factor Receptor Family | POSITIVELY REGULATES | Cell Population Proliferation |
| Cell Population Proliferation | OCCURS IN | Malignant Cell |
| Malignant Cell | PARTICIPATES IN | Thyroid Cancer, Papillary |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB09078#mechanism-of-action](https://go.drugbank.com/drugs/DB09078#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Papillary_thyroid_cancer](https://en.wikipedia.org/wiki/Papillary_thyroid_cancer)
